In the current study, we examined the potential role of TLR2 in CLL by analyzing the level of TLR2 expression on CD19+/CD5+ cells in peripheral blood in correlation with clinical and laboratory parameters characterizing disease activity and patients’ immune status. Here, CD5 is linked to B-cell chronic lymphocytic leukemia.